- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- June 2026
- 113 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£959GBP
- Report
- November 2023
- 30 Pages
Global
From €2467EUR$2,750USD£2,109GBP
- Report
- February 2026
- 125 Pages
Global
From €3500EUR$4,180USD£3,097GBP
Alpha 2 Agonists are a class of drugs used to treat a variety of conditions related to the Central Nervous System (CNS). These drugs act on the alpha-2 adrenergic receptor, which is found in the brain and other parts of the body. Alpha 2 Agonists are used to treat conditions such as anxiety, depression, insomnia, and pain. They can also be used to treat hypertension, glaucoma, and other conditions.
Alpha 2 Agonists are typically administered orally, intramuscularly, or intravenously. Common side effects of these drugs include drowsiness, dizziness, dry mouth, and constipation.
The Alpha 2 Agonist market is an important part of the CNS drug market. These drugs are used to treat a variety of conditions, and are often prescribed in combination with other drugs.
Some companies in the Alpha 2 Agonist market include Pfizer, Merck, GlaxoSmithKline, and Novartis. Show Less Read more